Search Results

DD DuPont de Nemours, Inc. - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
DD Stock | Fundamental Analysis & Investment Insights
NYSE Basic Materials Specialty Chemicals
Current Price Live
$42.86
Analyst Target
$48.12
+12.3% Upside
52W High
$44.17
52W Low
$22.5

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 17, 2026
Market cap
$17.96B
P/E
24.77
ROE
3.2%
Profit margin
-6.0%
Debt/Equity
0.4
Dividend yield
3.3%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
DuPont (DD) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for distress risk assessment. While the company demonstrates strong revenue growth and consistent earnings beat history, profitability is undermined by a negative net margin (-6.01%) and weak ROE (3.22%). Valuation appears stretched relative to Graham’s defensive standard ($46.13 vs. current $42.86), though below analyst target ($48.12). Bearish insider activity and a high dividend payout ratio (93%) raise sustainability concerns despite a solid yield (3.3%).

Key Strengths

Consistent quarterly earnings beats: 3 out of last 4 quarters beat estimates with strong average surprise of 8.28%
Revenue growth of 7.30% YoY outpaces sector average of 5.90%
Strong operating margin at 17.77%, well above sector average of 8.96%
Current ratio of 2.00 indicates solid short-term liquidity
Analyst consensus is strong_buy with a $48.12 target price, implying ~12% upside

Key Risks

Piotroski F-Score of 4/9 suggests weak financial health; below the 7+ threshold for strength
Negative profit margin (-6.01%) indicates net losses despite positive operating income
High dividend payout ratio (93.06%) threatens sustainability, especially with weak earnings coverage
Bearish insider sentiment: 4 sell transactions totaling $6.31M in last 6 months, no buys
Technical trend score of 10/100 signals strong bearish momentum near-term
AI Fair Value Estimate
Based on comprehensive analysis
$44.0
+2.7% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
55
Moderate
Value
55
Future
60
Past
65
Health
45
Dividend
50
AI Verdict
Neutral with upside risk if profitability improves
Key drivers: Revenue growth and operating margin strength, High analyst optimism, Weak net profitability and dividend risk, Bearish technicals and insider activity
Confidence
70%
Value
55/100

Ref P/E, PEG, Graham Number

Positives
  • Price below Graham Number ($42.86 vs $46.13) suggests slight undervaluation on defensive criteria
  • P/B of 0.78 indicates book value discount
Watchpoints
  • P/E of 24.77 is high given negative earnings and lack of PEG
  • Intrinsic value formula suggests deep undervaluation ($12.11), but conflicts with market and analyst view
Future
60/100

Ref Growth rates

Positives
  • Revenue growth of 7.30% YoY above peer average
  • Forward P/E of 19.81 suggests earnings recovery expectations
Watchpoints
  • Negative YoY EPS growth (-7.6%) and Q/Q decline (-2.7%)
  • No clear earnings growth visibility due to missing data
Past
65/100

Ref Historical trends

Positives
  • Long track record of beating earnings estimates (22 of 25 quarters)
  • Historical EPS surprises frequently above 10%
Watchpoints
  • Recent decline in EPS despite revenue growth
  • 1Y price performance (+36.5%) may be disconnected from fundamentals
Health
45/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Debt/Equity of 0.40 is conservative
  • Current ratio of 2.00 supports short-term solvency
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • ROE (3.22%) and ROA (3.46%) are very low
  • Quick ratio of 0.84 suggests potential liquidity pressure if receivables delayed
Dividend
50/100

Ref Yield, Payout

Positives
  • Dividend yield of 3.30% is attractive in current market
  • Current payout aligned with recent earnings (though high ratio)
Watchpoints
  • Payout ratio of 93.06% leaves little room for error
  • Dividend strength score of 20/100 indicates weak safety

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$42.86
Analyst Target
$48.12
Upside/Downside
+12.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for DD and closest competitors.

Updated 2026-01-16
Company 5Y 3Y 1Y 6M 1M 1W
DD
DuPont de Nemours, Inc.
Primary
+33.5% +46.4% +36.5% +37.0% +5.6% -2.2%
AGI
Alamos Gold Inc.
Peer
+472.0% +288.1% +116.2% +67.8% +7.6% +11.6%
DOW
Dow Inc.
Peer
-37.1% -42.6% -27.5% +0.1% +19.5% +4.7%
AA
Alcoa Corporation
Peer
+236.8% +22.0% +68.7% +103.0% +16.0% +3.6%
ALB
Albemarle Corporation
Peer
+13.7% -25.1% +115.4% +128.2% +27.6% +16.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
24.77
Forward P/E
19.81
PEG Ratio
N/A
P/B Ratio
0.78
P/S Ratio
1.4
EV/Revenue
2.02
EV/EBITDA
7.91
Market Cap
$17.96B

Profitability

Profit margins and return metrics

Profit Margin -6.01%
Operating Margin 17.77%
Gross Margin 37.12%
ROE 3.22%
ROA 3.46%

Growth

Revenue and earnings growth rates

Revenue Growth +7.3%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.4
Low debt
Current Ratio
2.0
Strong
Quick Ratio
0.84
Poor
Cash/Share
$4.67

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-10
$N/A
2025-11-06
$1.09
+11.2% surprise
2025-08-05
$1.12
+5.5% surprise
2025-05-02
$1.03
+8.1% surprise

Basic Materials Sector Comparison

Comparing DD against 41 companies in the Basic Materials sector (1 bullish, 21 neutral, 19 bearish)
P/E Ratio
24.77
This Stock
vs
30.38
Sector Avg
-18.5% (Discount)
Return on Equity (ROE)
3.22%
This Stock
vs
0.39%
Sector Avg
+715.2% (Excellent)
Profit Margin
-6.01%
This Stock
vs
-2.52%
Sector Avg
+138.2% (Superior)
Debt to Equity
0.4
This Stock
vs
0.61
Sector Avg
-34.5% (Less Debt)
Revenue Growth
7.3%
This Stock
vs
14.81%
Sector Avg
-50.7% (Slower)
Current Ratio
2.0
This Stock
vs
2.28
Sector Avg
-12.1% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
DD
DuPont de Nemours, Inc.
NEUTRAL $17.96B 24.77 3.2% -6.0% $42.86
AGI
Alamos Gold Inc.
NEUTRAL $18.23B 32.89 14.3% 33.5% $43.42
DOW
Dow Inc.
BEARISH $19.6B - -5.3% -2.8% $27.57
AA
Alcoa Corporation
BULLISH $16.11B 13.86 19.2% 8.9% $62.21
ALB
Albemarle Corporation
BEARISH $22.3B - 0.2% -0.4% $189.51

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-11-28 HOOVER ERIK THOMAS General Counsel Option Exercise 6,005 $168,140
2025-11-28 KOCH LORI Chief Executive Officer Option Exercise 9,011 $252,308
2025-11-28 HOOVER ERIK THOMAS General Counsel Sale 6,005 $238,939
2025-11-28 KOCH LORI Chief Executive Officer Sale 9,011 $355,574
2025-11-26 LOWERY FREDERICK M. Director Stock Award 982 $38,750
2025-11-26 BRADY AMY G Director Stock Award 206 $8,125
2025-11-26 CUTLER ALEXANDER M Director Stock Award 1,267 $50,000
2025-10-31 HOOVER ERIK THOMAS General Counsel Stock Award 23,079 -
2025-10-31 LARRABEE STEVEN P Chief Technology Officer Stock Award 13,078 -
2025-10-31 KOCH LORI Chief Executive Officer Stock Award 98,613 -
2025-10-31 RAIA CHRISTOPHER Officer Stock Award 19,232 -
2025-10-31 FRANZEN ANTONELLA B Chief Financial Officer Stock Award 20,755 -
2025-10-31 BREEN EDWARD D. Officer and Director Stock Award 192,332 -
2025-09-15 LARRABEE STEVEN P Chief Technology Officer Option Exercise 39,208 $2,419,578
2025-09-15 LARRABEE STEVEN P Chief Technology Officer Sale 43,208 $3,334,386
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
16 analysts
JP Morgan
2026-01-16
Maintains
Overweight Overweight
Keybanc
2026-01-09
Maintains
Overweight Overweight
UBS
2026-01-07
Maintains
Buy Buy
Mizuho
2025-12-18
Maintains
Outperform Outperform
RBC Capital
2025-11-18
Maintains
Outperform Outperform
Wells Fargo
2025-11-07
Maintains
Overweight Overweight
UBS
2025-11-07
Maintains
Buy Buy
Keybanc
2025-11-07
Maintains
Overweight Overweight
UBS
2025-11-05
Maintains
Buy Buy
Keybanc
2025-11-05
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning DD from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile